Brazil
  • pt
  • en
    • Search

    Explore Every Angle

    Thoroughly researched perspectives and commentary on the trends shaping global markets. Subscribe to Updates →

    Subscribe to Updates →

    What’s Trending

    04/11/24 Don’t Miss the Cyclical Opportunity in Emerging Market Equities
    03/01/24 Four Companies Leading the Rise of Lithium & Battery Technology: A 2024 Update
    03/01/24 The Enduring Case for U.S. Energy Infrastructure
    11/13/23 Spotlight on XYLD: An S&P 500 Covered Call Strategy
    Arelis “Lis” Agosto reset filter
    Insights Videos Reports
    Arelis “Lis” Agosto

    Arelis “Lis” Agosto

    Arelis (Lis) started with Global X in 2022 as a Research Analyst covering healthcare-related funds in the Thematic Growth suite of ETFs. Prior to joining Global X, she worked as a Senior Healthcare Analyst at Third Bridge, covering US life sciences, diagnostics, biotech, pharmaceutical services, and animal health. Lis holds a BA from Babson College in Business, with a concentration in Global Businesses Management. She is a native speaker of both English and Spanish.

    The Genomic Medicine Revolution

    Genomic medicines already have favorable risk/reward profiles, and improved manufacturing processes could cut costs and increase adoption. By Arelis Agosto

    There are no articles available.

    TERMS OF USE

    Global X Brasil Gestora de Investimentos Ltda. (“Global X Brasil”) is an asset manager authorized by the Brazilian Securities and Exchange Commission (“CVM”), constituted in the form of CVM Resolution No. 21/2021. Investing involves risks. The material on this site is for informational purposes only and does not constitute investment advice, recommendation, offer or solicitation to buy or sell any securities, funds, or strategies to any person in any jurisdiction in which an offer, solicitation, purchase, or sale would be illegal under the securities laws of such jurisdiction. Opinions expressed here are subject to change without notice. Reliance upon the information contained in this material is at the sole discretion of the reader. No securities regulator has confirmed the accuracy of any information contained herein. Access to the information on this site or the use of the services or information provided herein is prohibited by any person or entity in any jurisdiction or country where such distribution or use is contrary to local law, rules, or regulation. Investment in index funds (ETFs) involves risks, including detachment from the benchmark index and related to the liquidity of shares in the secondary market. Investment funds managed by Global X Brasil use strategies that can result in significant equity losses for their quota holders. Global X Brasil, its partners and employees are exempt of responsibility for any damages resulting directly or indirectly from the use of the information contained on this website.

    FOR EVALUATION OF THE PERFORMANCE OF AN INVESTMENT FUND, IT IS RECOMMENDED THE ANALYSIS OF AT LEAST 12 (TWELVE) MONTHS. INVESTMENT FUNDS DO NOT HAVE A GUARANTEE FROM THE ADMINISTRATOR, THE MANAGER, ANY INSURANCE MECHANISM OR CREDIT GUARANTEE FUND – FGC. INVESTMENTS IN FINANCIAL AND CAPITAL MARKETS ARE SUBJECT TO RISKS OF LOSS GREATER THAN THE TOTAL VALUE OF INVESTED CAPITAL. PAST PROFITABILITY DOES NOT REPRESENT A GUARANTEE OF FUTURE PROFITABILITY THE PROFITABILITY DISCLOSED IS NOT NET OF TAXES. READ THE PROSPECTUS, THE FORM OF COMPLEMENTARY INFORMATION, SHEET OF ESSENTIAL INFORMATION AND THE REGULATION BEFORE INVESTING. DESCRIPTION OF THE ANBIMA TYPE AVAILABLE IN THE FORM OF COMPLEMENTARY INFORMATION.

    Back to Top